Our Promise to You

Guaranteed product quality, expert customer support

Our Promise to You

ELF-153

  • Specification
  • Recommended Products
Cat.No.
CSC-C0674
Description
Established 1988 from a 41-year-old man with acute myeloid leukemia (AML-M7) during refractory relapse initially presenting with acute myelofibrosis
Species
Human
Source
acute myeloid leukemia
Recommended Medium
80% RPMI-1640 + 20% h.i. FBS + 5 ng/ml GM-CSF
Culture Properties
suspension
Morphology
round cells growing singly in suspension; occasional semi adherent cells present; a few giant cells present
Karyotype
Human hypodiploid karyotype with 8% polyploidy; 42(40-43)<2n>X, -Y, -7, -14, -17, del(5)(q13q32), der(6)t(6;7)(p23;p11), i(7)(q10), der(12)t(12;14)(p12;q11), add(20)(q13)x1-2; matches published karyotype
Quality Control
Mycoplasma: negative in microbiological culture, PCR assays
Immunology: CD3 -, CD4 +, CD13 +, CD14 -, CD15 -, CD19 -, CD33 +, CD34 +, HLA-DR +
Viruses: PCR: EBV -, HBV -, HCV -, HIV -, HTLV-I/-II -
Storage and Shipping
Frozen with 70% medium, 20% FBS, 10% DMSO at about 10 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

For research use only. Not for any other purpose.

  • Q & A
  • Customer Review
Q:
What are the advantages of STR analysis?
A:

Relatively inexpensive, fast turnaround time, highly sensitive, and high abundance detection range。

Ask a Question

Average Rating: 4.0    |    1 Scientist has reviewed this product

High quality

The quality of the tumor cell products from Creative Bioarray is backed by rigorous quality control measures, including cell viability and purity testing.

29 June 2022


Ease of use

After sales services

Value for money


Write your own review

Customer Support & Price Inquiry

Verification Code